Develops effective therapeutics for orphan tauopathies
Asceneuron has raised €27M across 1 funding round from 1 investor, most recently a Series A round in Sep 2015. Based in Lausanne, Switzerland; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-09-01 | Series A | €27M |
| Sofinnova Partners |
| View deal → |
